Neutralizing Th2 inflammation in neonatal islets prevents β-cell failure in adult IUGR rats

Diabetes

Volumn 63, Issue 5, 2014, Pages 1672-1684

  Jaeckle Santos, Lane J ^a,b   Li, Changhong ^a,b   Doulias, Paschalis Thomas ^b   Ischiropoulos, Harry ^a,b   Worthen, G Scott ^a,b   Simmons, Rebecca A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, NEUTRALIZING; FETAL GROWTH RETARDATION; INFLAMMATION; INSULIN-SECRETING CELLS; INTERLEUKIN-4; ISLETS OF LANGERHANS; RATS; TH2 CELLS;

EID: 84899124255     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1226     Document Type: Article

References (44)

1. Simmons RA. Developmental origins of adult disease. Pediatr Clin North Am 2009;56:449-466
2. Gatford KL, Simmons RA, De Blasio MJ, Robinson JS, Owens JA. Review: placental programming of postnatal diabetes and impaired insulin action after IUGR. Placenta 2010;31(Suppl.):S60-S65
3. Homo-Delarche F, Calderari S, Irminger JC, et al. Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat. Diabetes 2006;55:1625-1633 (Pubitemid 44324114)
4. Masuyama T, Komeda K, Hara A, et al. Chronological characterization of diabetes development in male Spontaneously Diabetic Torii rats. Biochem Biophys Res Commun 2004;314:870-877 (Pubitemid 38112880)
5. Donath MY, Størling J, Maedler K, Mandrup-Poulsen T. Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med (Berl) 2003;81:455-470 (Pubitemid 37070198)
6. Kolb H, Mandrup-Poulsen T. An immune origin of type 2 diabetes? Diabetologia 2005;48:1038-1050 (Pubitemid 40909636)
7. Takeda Y, Wakabayashi I. Alteration in lymphocyte population and humoral immune response in type 2 diabetic Goto-Kakizaki rats. Life Sci 2012;90:545-552
8. Bhargava P, Lee CH. Role and function of macrophages in the metabolic syndrome. Biochem J 2012;442:253-262
9. Mantovani A, Sica A, Locati M. New vistas on macrophage differentiation and activation. Eur J Immunol 2007;37:14-16 (Pubitemid 46128780)
10. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004;4:583-594
11. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003;8:223-246 (Pubitemid 37099886)
12. Denney L, Kok WL, Cole SL, Sanderson S, McMichael AJ, Ho LP. Activation of invariant NKT cells in early phase of experimental autoimmune encephalomyelitis results in differentiation of Ly6Chi inflammatory monocyte to M2 macrophages and improved outcome. J Immunol 2012;189:551-557
13. Donath MY, Böni-Schnetzler M, Ellingsgaard H, Halban PA, Ehses JA. Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends Endocrinol Metab 2010;21:261-267
14. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011;11:98-107
15. Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356:1517-1526 (Pubitemid 46588416)
16. Cavelti-Weder C, Babians-Brunner A, Keller C, et al. Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 2012;35:1654-1662
17. Ramos-Zavala MG, González-Ortiz M, Martínez-Abundis E, Robles-Cervantes JA, González-López R, Santiago-Hernández NJ. Effect of diacerein on insulin secretion and metabolic control in drug-naive patients with type 2 diabetes: a randomized clinical trial. Diabetes Care 2011;34:1591-1594
18. Simmons RA, Templeton LJ, Gertz SJ. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 2001;50:2279-2286 (Pubitemid 33641912)
19. Simmons RA, Suponitsky-Kroyter I, Selak MA. Progressive accumulation of mitochondrial DNA mutations and decline in mitochondrial function lead to beta-cell failure. J Biol Chem 2005;280:28785-28791 (Pubitemid 41105780)
20. Stoffers DA, Desai BM, DeLeon DD, Simmons RA. Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat. Diabetes 2003;52:734-740 (Pubitemid 36323581)
21. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-5121 (Pubitemid 32397092)
22. Ham JN, Crutchlow MF, Desai BM, Simmons RA, Stoffers DA. Exendin-4 normalizes islet vascularity in intrauterine growth restricted rats: potential role of VEGF. Pediatr Res 2009;66:42-46
23. Carr RM, Patel RT, Rao V, et al. Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice. Am J Physiol Regul Integr Comp Physiol 2012;302:R996-R1003
24. Holers VM. The spectrum of complement alternative pathway-mediated diseases. Immunol Rev 2008;223:300-316 (Pubitemid 351986186)
25. Krug N, Tschernig T, Erpenbeck VJ, Hohlfeld JM, Köhl J. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am J Respir Crit Care Med 2001;164:1841-1843 (Pubitemid 33152317)
26. Taube C, Thurman JM, Takeda K, et al. Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation. Proc Natl Acad Sci USA 2006;103:8084-8089 (Pubitemid 43801056)
27. Koistinen HA, Koivisto VA, Andersson S, et al. Leptin concentration in cord blood correlates with intrauterine growth. J Clin Endocrinol Metab 1997;82:3328-3330 (Pubitemid 27419081)
28. Setia S, Sridhar MG, Bhat V, Chaturvedula L, Vinayagamoorti R, John M. Insulin sensitivity and insulin secretion at birth in intrauterine growth retarded infants. Pathology 2006;38:236-238 (Pubitemid 43879719)
29. Kamei N, Tobe K, Suzuki R, et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 2006;281:26602-26614 (Pubitemid 44401869)
30. Joss-Moore LA, Wang Y, Campbell MS, et al. Uteroplacental insufficiency increases visceral adiposity and visceral adipose PPARgamma2 expression in male rat offspring prior to the onset of obesity. Early Hum Dev 2010;86:179-185
31. Morioka T, Asilmaz E, Hu J, et al. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest 2007;117:2860-2868 (Pubitemid 47529616)
32. Mestan K, Ouyang F, Matoba N, Pearson C, Ortiz K, Wang X. Maternal obesity, diabetes mellitus and cord blood biomarkers in large-for-gestational age infants. J Pediatr Biochem 2010;1:217-224
33. Kiguchi N, Maeda T, Kobayashi Y, Fukazawa Y, Kishioka S. Leptin enhances CC-chemokine ligand expression in cultured murine macrophage. Biochem Biophys Res Commun 2009;384:311-315
34. Corbett JA, Lancaster JR Jr, Sweetland MA, McDaniel ML. Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion. J Biol Chem 1991;266:21351-21354 (Pubitemid 121000188)
35. Welsh N, Eizirik DL, Bendtzen K, Sandler S. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 1991;129:3167-3173
36. Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT, Corbett JA. IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest 1998;102:516-526 (Pubitemid 28376154)
37. Hong KH, Cho ML, Min SY, et al. Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Clin Exp Immunol 2007;147:573-579
38. Mathis D, Shoelson SE. Immunometabolism: an emerging frontier. Nat Rev Immunol 2011;11:81
39. Sjöholm A, Nyström T. Inflammation and the etiology of type 2 diabetes. Diabetes Metab Res Rev 2006;22:4-10 (Pubitemid 43154455)
40. Imai Y, Dobrian AD, Morris MA, Nadler JL. Islet inflammation: a unifying target for diabetes treatment? Trends Endocrinol Metab 2013;24: 351-360
41. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993;14:353-356 (Pubitemid 23198169)
42. Prescott SL, Macaubas C, Holt BJ, et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 1998;160: 4730-4737 (Pubitemid 28215305)
43. Duijts L. Fetal and infant origins of asthma. Eur J Epidemiol 2012;27:5-14
44. Steffensen FH, Sørensen HT, Gillman MW, et al. Low birth weight and preterm delivery as risk factors for asthma and atopic dermatitis in young adult males. Epidemiology 2000;11:185-188 (Pubitemid 30112021)